BioNTech shares surge as vaccine-maker's profits soar on booming outlook

CBC News | Aug. 9, 2021, 10:31 a.m. | Original

German pharmaceutical maker BioNTech, which developed the first widely used coronavirus vaccine with Pfizer, swung to a huge profit in the second quarter on record sales.

Taliban takes 2 more provincial capitals in relentless Afghanistan offensive Some B.C. evacuation alerts lifted as rain lowers wildfire danger, but relief not expected to last